KRAS is the most frequently mutated isoform among the RAS family of genes and is associated with an overall percentage of 75–83% of all RAS-mutated cancers, whereas NRAS is detected in only 8–17% and HRAS in 3–7% of all cases. Here, KRAS is linked to cancer.